Martis Capital

Martis Capital is a Washington, DC-based middle-market private equity firm investing exclusively in healthcare. The firm’s stated approach emphasizes collaboration with management teams in companies operating in complex regulatory environments, and the sub-vertical focus is Care Delivery and Tech-Enabled Services. No AI-specific thesis is disclosed.

Martis writes growth-stage checks of $25M and up. Geographic focus is the United States. Specific named portfolio companies and team members are not provided in the record here; founders should consult the Martis website and any recent transaction press to understand current portfolio composition and which partners cover which sub-sectors.

The practical guidance for founders is the standard PE caveat. If you are an early-stage AI software company in healthcare, Martis is not your investor. If you run a profitable services business in a regulated category such as behavioral health, post-acute care, specialty practice management, or compliance-heavy clinical services, the regulatory-environment framing is the angle that may resonate. Bring a clear EBITDA story, a credible plan for navigating reimbursement or licensure dynamics, and a willingness to engage in a control or significant minority transaction.